Ethiopropamine
Clinical data | |
---|---|
Other names | EPA; N-Ethylthiopropamine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
Chemical and physical data | |
Formula | C9H15NS |
Molar mass | 169.29 g·mol−1 |
3D model (JSmol) | |
| |
|
Ethiopropamine (EPA), also known as N-ethylthiopropamine, is a stimulant drug which is the ethyl homologue of methiopropamine, or the thiophene analogue of ethamphetamine. It has been sold as a designer drug, first identified in Slovenia in 2021.[1]
See also
References
- ^ "Analytical Report Ethiopropamine" (PDF). Nacionalni Forenzicni Laboratorij. 23 July 2021.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.